Claimalytics Launches atlas-ai: An Agentic AI Platform Purpose-Built for Healthcare, PBMs & Patients
The Floridant/10331830

TAMPA, Fla. - Floridant -- Claimalytics, LLC today announced the launch of atlas-ai, a first-of-its-kind agentic AI platform designed specifically for the healthcare industry. atlas-ai launches with 12 purpose-built AI agents organized across three operational tiers, with additional agents in continuous development, to transform how health plans, pharmacy benefit managers (PBMs), and provider organizations handle the most complex, time-intensive workflows in pharmacy benefit management.

atlas-ai Platform Overview
atlas-ai is architected around a three-tier agent framework that mirrors the operational structure of pharmacy benefit management.

Built on Public Drug Data Infrastructure
atlas-ai leverages a proprietary drug data resolution pipeline built on RxNorm, the National Library of Medicine's drug normalization standard. By resolving drug identifiers at the Semantic Clinical Drug (SCD) level using RxCUI, atlas-ai can reliably match free-text drug names, NDC codes, and formulary entries across manufacturer and labeling variations. The platform also integrates data from CMS (NADAC, Medicare Part D, ASP), the FDA NDC Directory, DailyMed labeling, and state Medicaid Preferred Drug Lists to deliver real-time formulary intelligence and drug pricing context.

More on The Floridant

• Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
• AI for Business Global Summit Faculty Includes Emmy-Nominated Producer, LinkedIn Expert
• Vargas Rentals Launches New Website for Fort Myers Party Rentals
• Nonprofit partnership provides foster families with museum memberships
• Suncoast Credit Union Announces $25,000 Hunger Action Month match for Harry Chapin Food Bank

Private AI Models with Verified, Controlled Sources
All Claimalytics products and agents are powered by private AI models that operate within a controlled data environment. Unlike general-purpose AI systems that draw from the open internet, atlas-ai and its agents do not have unrestricted access to external web content. Every source referenced, cited, or used by the AI models has been vetted, verified, and approved by Claimalytics before it enters the platform's knowledge base.

This controlled-source architecture is a deliberate design decision for the healthcare industry, where accuracy and traceability are not optional. By restricting the AI models to approved data sources such as CMS publications, FDA databases, DailyMed labeling, RxNorm, state Medicaid formularies, and other verified clinical and regulatory references, Claimalytics ensures that every response, recommendation, and output generated by the platform is grounded in material that meets the company's standards for reliability and clinical validity. No unverified, uncontrolled, or unapproved internet content is used by any Claimalytics agent or product.

More on The Floridant

• Brian Cassell joins Stevens Construction as chief financial officer
• 'Drive Out Hunger' golf tournament expands to two days
• Florida: Flags at Half-Staff in Honor of Patriot Day
• Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
• GentlePath360 Partners With Trust & Will to Offer Estate-Planning Resources

View Full Press Release: https://www.claimalytics.com/newsroom/atlas-ai-launch

About Claimalytics
Claimalytics, LLC is a Tampa-based healthcare technology company building AI-powered analytics and automation products for the pharmacy benefit management industry. The company's product suite, including atlas-ai, cortex-ai, and claim analyzer, is designed to bring intelligence, transparency, and efficiency to the most complex workflows in healthcare. For more information, visit claimalytics.com.